NATION
WORLD
STATES
OPINIONS
CITIES
BUSINESS
SPORT
GOOD NEWS
MOVIES
PHOTOS
VIDEOS
WEB SCRAWL
E-PAPER
NATION
WORLD
STATES
OPINIONS
CITIES
BUSINESS
SPORT
GOOD NEWS
MOVIES
PHOTOS
VIDEOS
WEB SCRAWL
E-PAPER
Central Drug Standards Control Organisation
Nation
Regulator waived phase three trial to clear COVID-19 drug Itolizumab as India cases continue to rise
Sumi Sukanya Dutta
14 Jul 2020
2 min read
X
The New Indian Express
www.newindianexpress.com
INSTALL APP